After publishing its predictions for digital pathology in 2026, Signify Research wanted to test those forecasts against clinical reality. Imogen Fitt and Alan Stoddart spoke with seven practising pathologists and laboratory leaders across academic and health system laboratories to find out what pathologists want from digital pathology.
At Signify Research, we spend a lot of time speaking with the vendors shaping the health technology and life sciences markets. Through our dedicated Digital Pathology Market Intelligence Service, we work closely with digital pathology vendors, life sciences companies, investors and adjacent technology providers across the ecosystem.
But understanding a market properly requires more than simply tracking vendors. Our research combines extensive primary research interviews with ongoing secondary market monitoring to ensure that strategic decisions are grounded in the clinical and operational realities of pathology laboratories.
This means analysing vendor-reported data to size the market, forecast competitive share and understand vendor strategies. Alongside this, we conduct regular end-user studies to explore how pathologists and laboratories actually view the market, including vendor perception, pricing dynamics and purchasing behaviour.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.